Developmental Compound

Product Astellas Pharma US Inc
Total Payments
$61,992
Transactions
26
Doctors
12
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $61,992 26 12

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $60,040 11 96.9%
Travel and Lodging $1,494 7 2.4%
Food and Beverage $458.71 8 0.7%

Top Doctors Receiving Payments for Developmental Compound

Doctor Specialty Location Total Records
, MD Hematology & Oncology New York, NY $7,271 2
, MD Internal Medicine Baltimore, MD $6,832 2
, DR Medical Oncology Boston, MA $6,784 3
, MD Gastroenterology Santa Monica, CA $6,211 2
, MD Hematology Atlanta, GA $5,686 3
, M.D Internal Medicine Los Angeles, CA $5,254 2
, M.D Hematology & Oncology Rochester, MN $5,216 3
, MD, MPH Hematology & Oncology Tampa, FL $5,112 3
, D.O Hematology & Oncology Phoenix, AZ $5,097 3
, M.D Hematology & Oncology Houston, TX $4,690 1
, MD Hematology & Oncology La Jolla, CA $3,750 1
, MD Medical Oncology New York, NY $91.49 1

About Developmental Compound

Developmental Compound is a product associated with $61,992 in payments to 12 healthcare providers, recorded across 26 transactions in the CMS Open Payments database. The primary manufacturer is Astellas Pharma US Inc.

Payment data is available from 2017 to 2017. In 2017, $61,992 was paid across 26 transactions to 12 doctors.

The most common payment nature for Developmental Compound is "Consulting Fee" ($60,040, 96.9% of total).